Epstein Secrets

heir liquidation preference. Based on discussions with management, all preferred shares shall accrue non-cumulative dividends as and if declared by the Board of Directors on an annual basis. If declared, all preferred shareholders (i.e. Series 5, 4, 3, 2,1-A, and i-C) shall be entitled to receive dividends at the rat

ear holding period. Therefore, hereafter, references to the FMV study refer only to those securities with a two-year holding period. CONFIDENTIAL i wras LLC 74 EFTA00307469 WTAS ALIPHCOM - COMMON EQUITY VALUATION REPORT As of June 20, 2011 • Market Price Volatility. Companies with greater volatilit

heir liquidation preference. Based on discussions with management, all preferred shares shall accrue non-cumulative dividends as and if declared by the Board of Directors on an annual basis. If declared, all preferred shareholders (i.e. Series 5, 4, 3, 2,1-A, and i-C) shall be entitled to receive dividends at the rat

ear holding period. Therefore, hereafter, references to the FMV study refer only to those securities with a two-year holding period. CONFIDENTIAL i wras LLC 74 EFTA00307368 WTAS ALIPHCOM - COMMON EQUITY VALUATION REPORT As of June 20, 2011 • Market Price Volatility. Companies with greater volatilit

heir liquidation preference. Based on discussions with management, all preferred shares shall accrue non-cumulative dividends as and if declared by the Board of Directors on an annual basis. If declared, all preferred shareholders (i.e. Series 5, 4, 3, 2,1-A, and i-C) shall be entitled to receive dividends at the rat

ear holding period. Therefore, hereafter, references to the FMV study refer only to those securities with a two-year holding period. CONFIDENTIAL i wras LLC 74 EFTA00307267 WTAS ALIPHCOM - COMMON EQUITY VALUATION REPORT As of June 20, 2011 • Market Price Volatility. Companies with greater volatilit